ROLLING MEADOWS, IL, Feb. 05, 2018 -- OneLife Technologies Corp. (“OneLife” or the “Company”) (OTC PINK: OLMM), a mobile medical data and technologies company, today provided this report highlighting the Company’s recent agreement to acquire 100% of Yinuo Technologies Ltd., a Chinese-based developer of mobile communications technologies.
On December 22, 2017, OneLife entered into a Stock Purchase Agreement with Fang Sun, pursuant to which the Company contracted to acquire 100% of the issued and outstanding capital stock of Yinuo Technologies Ltd. (“Yinuo”) in exchange for $500,000 and 40,000,000 shares of the Company’s common stock. Also, pursuant to the agreement, the current management of Yinuo, including founder and CEO, Fang Sun, will join OneLife as senior employees.
Focused primarily in the Chinese marketplace, Yinuo develops, manufactures and markets a series of mobile and handheld medical grade devices for medical and healthcare services. Yinuo provides a complete cloud system of mobile healthcare with various hospitals, extending the services to discharged patients. Yinuo’s technologies have been used in over 100 hospitals across China.
In addition to Yinuo’s considerable experience in development and deployment of wearable medical tracking technologies to hospitals in China, Yinuo’s business assets and intellectual property consist of several patents, patents pending, copyrights, and trademarks. This includes the invention patent “A Method of Sensor Watch for Remote Acquisition and Monitoring of Physiological Signs and States” (No.: 201310748019.X), the invention patent “A device for Monitoring States of Infants’ Health and Emotions” (No.: 201310747594.8) and the appearance patent “ID Design for a Sensor Watch” (No.: ZL.2014.3.0050904.6).
Robert J. Wagner, CEO of OneLife, commented, “The complete acquisition of Yinuo Technologies by OneLife will elevate our current development partnership to the next level and position the combined companies and management teams to take full advantage of Yinuo’s proven and award winning wearable medical tracking device technologies and OneLife’s sales experience and strategic access to the U.S. healthcare system and U.S. capital markets.”
“Based on Yinuo’s previous expansion rates and revenue generation with installations across China, we are very excited for the opportunity to aggressively build upon their past success with a stronger combined team to launch this proven technology and business model across the U.S.A.”
Closing of the acquisition of Yinuo Technologies Ltd. by OneLife is subject to customary terms and conditions, including receipt of (i) a formal Calculation Valuation and Appraisal Report and (ii) two years of audited financial statements audited by a Public Company Accounting Oversight Board registered and approved audit firm. The Company anticipates closing the acquisition within 45-60 days.
For additional information regarding OneLife Technologies Corp., visit www.onelifetc.com.
About OneLife Technologies Corp.
OneLife Technologies Corp. (OTC Pink: OLMM), is a mobile medical software/data collection company with a suite of proprietary, patented, medical grade wearable tracking technologies designed to provide patients, physicians, nursing homes, and hospitals with 24/7 real-time centralized, personal, comprehensive health data. The Company files periodic reports with the Securities and Exchange Commission, which can be viewed at www.sec.gov.
FORWARD LOOKING STATEMENT
This news release includes forward-looking statements that reflect OneLife Technologies Corp. current expectations about its future results, performance, prospects and opportunities OneLife Technologies Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities for the remainder of 2018 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.
Contact: OneLife Technologies Corp. [email protected]


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Washington Post Publisher Will Lewis Steps Down After Layoffs
Anta Sports Expands Global Footprint With Strategic Puma Stake
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



